Bumetanide and Actinic keratosis - a phase IV clinical study of FDA data


Actinic keratosis is reported only by a few people who take Bumetanide.

The phase IV clinical study analyzes which people take Bumetanide and have Actinic keratosis. It is created by eHealthMe based on reports of 17,150 people who have side effects while taking Bumetanide from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

17,150 people reported to have side effects when taking Bumetanide.
Among them, 5 people (0.03%) have Actinic keratosis.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 17,317 Bumetanide users for its effectiveness, alternative drugs and more.

What is Actinic keratosis?

Actinic keratosis (skin disease due to sun exposure) is found to be associated with 1,376 drugs and 838 conditions by eHealthMe.

Number of Bumetanide and Actinic keratosis reports submitted per year:

Could Bumetanide cause Actinic keratosis?

Time on Bumetanide when people have Actinic keratosis *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 100 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Actinic keratosis when taking Bumetanide *:

  • female: 20 %
  • male: 80 %

Age of people who have Actinic keratosis when taking Bumetanide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Bumetanide *:

  1. Zaroxolyn: 2 people, 40.00%
  2. Lisinopril: 2 people, 40.00%
  3. Amaryl: 2 people, 40.00%
  4. Ambien: 2 people, 40.00%
  5. Aspirin: 2 people, 40.00%
  6. Atenolol: 2 people, 40.00%
  7. Demadex: 2 people, 40.00%
  8. Flomax: 2 people, 40.00%
  9. Flovent: 2 people, 40.00%
  10. Glucophage: 2 people, 40.00%

Common side effects people have besides Actinic keratosis *:

  1. Cardiac Failure Congestive: 3 people, 60.00%
  2. Renal Impairment (severely reduced kidney function): 3 people, 60.00%
  3. Abdominal Distension: 2 people, 40.00%
  4. Splenomegaly (enlargement of spleen): 2 people, 40.00%
  5. Pleural Effusion (water on the lungs): 2 people, 40.00%
  6. Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 2 people, 40.00%
  7. Cataract (clouding of the lens inside the eye): 2 people, 40.00%
  8. Calculus Bladder (bladder stone): 2 people, 40.00%
  9. Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 2 people, 40.00%
  10. Breathing Difficulty: 2 people, 40.00%

Common conditions people have *:

  1. Type 2 Diabetes: 2 people, 40.00%
  2. Cough: 2 people, 40.00%
  3. Weight Increased: 1 person, 20.00%
  4. Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 20.00%
  5. Pain: 1 person, 20.00%
  6. Oedema (fluid collection in tissue): 1 person, 20.00%
  7. Neuropathy Peripheral (surface nerve damage): 1 person, 20.00%
  8. Nerve Compression: 1 person, 20.00%
  9. Myositis (inflammation of the muscles): 1 person, 20.00%
  10. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and have Actinic keratosis?

Check whether Actinic keratosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Actinic keratosis and when was it recovered:

Expand to all the drugs that have ingredients of bumetanide:

Alternative drugs to, pros and cons of Bumetanide:

Common Bumetanide side effects:

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Actinic keratosis treatments and more:

COVID vaccines that are related to Actinic keratosis:

Common drugs associated with Actinic keratosis:

All the drugs that are associated with Actinic keratosis:

Common conditions associated with Actinic keratosis:

All the conditions that are associated with Actinic keratosis:

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide (the active ingredients of Bumetanide) and Bumetanide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: